Harry McNamara net worth
Quick answer
Harry McNamara's estimated net worth is $14.0M (range $9.8M – $21.0M) as of 2026. Harry McNamara is Founder at C16 Biosciences. C16 Biosciences valuation.
Harry McNamara is Founder at C16 Biosciences (YC S18). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: B.S. in Chemical Engineering from MIT
- Region: United States of America
- Industries: Healthcare, Industrial Bio
- Team size: 35
- Website: https://www.c16bio.com/
Who is Harry McNamara?
Harry McNamara is a founder at C16 Biosciences, which was part of Y Combinator's S18 batch. He focuses on developing sustainable alternatives to palm oil.
Highlights:
- Massachusetts Institute of Technology
- University of Cambridge
- Worked on sustainable energy solutions
About C16 Biosciences
C16 Biosciences is decarbonizing consumer products supply chains by producing next-generation ingredients. The company's biomanufacturing platform produces better performing, more sustainable alternatives to oils and fats, and their first product is an alternative to palm oil. The company owns and operates Palmless™ alternative fats and oils.
FAQ: Harry McNamara net worth and C16 Biosciences valuation
What is Harry McNamara's net worth?
Harry McNamara's estimated net worth is $14.0M (range $9.8M – $21.0M) as of 2026. Harry McNamara is Founder at C16 Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is C16 Biosciences valuation?
C16 Biosciences's estimated valuation on Entrepreneurial Check is $200.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Harry McNamara's role?
Harry McNamara is Founder at C16 Biosciences, a Y Combinator-backed startup (batch S18).